Methyl sulfonyl methane-containing composition for preventing or alleviating obesity, fatty liver, and diabetes
OwnerSeung Hoon LEE, Tae Kyung LEEinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerSeung Hoon LEE, Tae Kyung LEEinventors
Estimating the term…
The present invention relates to a methyl-sulfonyl methane containing composition for preventing or alleviating obesity, fatty liver and diabetes. An MSM (methyl sulfonyl methane: dimethyl sulfone)-containing composition according to the present invention, which contains 75 to 85 wt. % of MSM, 0.5 to 2 wt. % of vitamin B6 hydrochloride, 0.01 to 1 wt. % of folic acid, 2 to 8 wt. % of galacto-oligosaccharide, 10 to 18 wt. % of rice-fermented magnesium, and 0.5 to 3 wt. % of vitamin C, not only can prevent and treat obesity by reducing the size of fat cells and inhibiting differentiation of mature fat cells, but also lowers triglyceride and the total cholesterol concentration in the liver, thus having a fatty liver preventing effect, and also reduces the concentration of insulin-like growth factor, thus also being effective for diabetes. Therefore, the MSM-containing composition is expected to be useful as a pharmaceutical composition and food composition for preventing and alleviating obesity, fatty liver and diabetes.
A pharmaceutical composition for preventing or treating obesity, comprising:
A pharmaceutical composition for preventing or treating fatty liver, comprising:
A pharmaceutical composition for preventing or treating diabetes, comprising:
A food composition for preventing or alleviating obesity, comprising:
A food composition for preventing or improving fatty liver, comprising:
A food composition for preventing or alleviating diabetes, comprising:
Dependencies are inferred from the claim text.